FrancophonIA/ELRC3.0 huggingface dataset:
English: Advagraf therapy should be initiated after considering ciclosporin blood concentrations and the clinical condition of the patient.
Slovenian: Zdravljenje z zdravilom Advagraf je treba začeti upoštevaje koncentracijo ciklosporina v krvi in bolnikovo klinično stanje.
English: Use all the capsules within 1 year of opening the aluminium wrapping and before the expiry date.
Slovenian: Vse kapsule morate porabiti v 1 letu po odprtju aluminijastega ovoja in pred datumom izteka roka uporabnosti zdravila.
English: Avoid grapefruit (also as juice) while on treatment with Advagraf, since it can affect its levels in the blood.
Slovenian: Med jemanjem zdravila Advagraf se morate izogibati uživanju grenivk (tudi v obliki soka), ker lahko vplivajo na njegove vrednosti v krvi.
English: Following your organ transplant (liver, kidney), your body's immune system will try to reject the new organ.
Slovenian: Po presaditvi organa (jeter, ledvic) telo poskuša zavrniti novi organ.
English: Neoplasms benign, malignant and unspecified Patients receiving immunosuppressive therapy are at increased risk of developing malignancies.
Slovenian: Benigne, maligne in neopredeljene novotvorbe Bolnike, ki prejemajo imunosupresive, bolj ogroža pojav malignomov.
English: Results from clinical trials performed with once-daily tacrolimus Advagraf Liver transplantation
Slovenian: Rezultati iz kliničnih preskušanj, izvedenih z odmerjanjem takrolimusa (Advagraf) enkrat dnevno Presaditev jeter
English: In patients unable to take oral medicinal products during the immediate post-transplant period, tacrolimus therapy can be initiated intravenously (see Summary of Product Characteristics for Prograf 5 mg/ml concentrate for solution for infusion) at a dose approximately 1/5th of the recommended oral dose for the corresponding indication.
Slovenian: Pri bolnikih, pri katerih jemanje peroralnih oblik zdravila takoj po presaditvi ni možno, se zdravljenje s takrolimusom lahko uvede intravensko (glejte povzetek glavnih značilnosti zdravila Prograf 5 mg/ml koncentrat za raztopino za infundiranje) v odmerku, ki je približno 1/5 priporočenega peroralnega odmerka za ustrezno indikacijo.
English: Use all the prolonged-release hard capsules within 1 year of opening the aluminium wrapping.
Slovenian: Vse trde kapsule s podaljšanim sproščanjem morate porabiti v 1 letu po odprtju aluminijastega ovoja.
English: It is not recommended that Advagraf is taken with ciclosporin (another medicine used for the prevention of transplant organ rejection).
Slovenian: Jemanje zdravila Advagraf skupaj s ciklosporinom (drugo zdravilo, ki se uporablja za preprečevanje zavrnitve organa po presaditvi) ni priporočljivo.
English: At the molecular level, the effects of tacrolimus appear to be mediated by binding to a cytosolic protein (FKBP12) which is responsible for the intracellular accumulation of the compound.
Slovenian: Kaže, da učinke takrolimusa na molekulski ravni sproži vezava na citosolno beljakovino (FKBP12), ki je odgovorna za njegovo znotrajcelično kopičenje.
English: You may also be given Advagraf for an ongoing rejection of your transplanted liver, kidney, heart or other organ when any previous treatment you were taking was unable to control this immune response after your transplantation.
Slovenian: Zdravilo Advagraf lahko dobite tudi zaradi zavračanja presajenih jeter, ledvic, srca ali drugega organa, oziroma če zdravila, ki ste jih jemali pred tem, niso obvladala imunskega odziva po presaditvi.
English: If abnormalities develop, dose reduction of Advagraf, or change of treatment to another immunosuppressive agent should be considered.
Slovenian: Če se pojavijo nenormalnosti, je treba razmisliti o zmanjšanju odmerka zdravila Advagraf ali o prehodu na drugo imunosupresivno zdravilo.
English: Other potential interactions that may increase systemic exposure of tacrolimus include prokinetic agents (such as metoclopramide and cisapride), cimetidine and magnesium-aluminium-hydroxide.
Slovenian: Druge možne interakcije, ki lahko povečajo sistemsko izpostavljenost takrolimusa vključujejo interakcije s propulzivi (kot sta metoklopramid in cisaprid), cimetidinom in magnezijevim/aluminijevim hidroksidom.
English: Make sure that you receive the same tacrolimus medicine every time you collect your prescription, unless your transplant specialist has agreed to change to a different tacrolimus medicine.
Slovenian: Ko greste z receptom v lekarno, se vedno prepričajte, da ste dobili enako zdravilo s takrolimusom, razen če se je zdravnik, strokovnjak za presaditve, strinjal z zamenjavo z drugim zdravilom s takrolimusom.
English: Advagraf should generally be administered on an empty stomach or at least 1 hour before or 2 to 3 hours after a meal, to achieve maximal absorption (see section 5.2).
Slovenian: Za dosego največje absorpcije je treba zdravilo Advagraf praviloma jemati na prazen želodec ali vsaj 1 uro pred ali 2 do 3 ure po jedi (glejte poglavje 5.2).
English: If you have accidentally taken too much Advagraf, contact your doctor or nearest hospital emergency department immediately.
Slovenian: Če ste vzeli večji odmerek zdravila Advagraf, kot bi smeli Če ste po nesreči vzeli preveč zdravila Advagraf, se takoj obrnite na svojega zdravnika ali oddelek za nujno pomoč v najbližji bolnišnici.
English: Advagraf blood levels can be affected by other medicines you take, and blood levels of other medicines can be affected by taking Advagraf, which may require interruption, an increase or a decrease in Advagraf dose.
Slovenian: Druga zdravila, ki jih jemljete, lahko vplivajo na koncentracijo zdravila Advagraf v krvi, pa tudi jemanje zdravila Advagraf lahko vpliva na koncentracijo drugih zdravil v krvi, zato utegne biti potrebna prekinitev, povečanje ali zmanjšanje odmerka zdravila Advagraf.
English: By Day 4, systemic exposure as measured by trough levels is similar for both kidney and liver transplant patients with both formulations.
Slovenian: 4. dan je bila sistemska izpostavljenost na osnovi najnižjih koncentracij enaka, tako pri bolnikih s presajeno ledvico kot bolnikih s presajenimi jetri, pri obeh farmacevtskih oblikah.
English: The capsules should be swallowed whole with fluid (preferably water).
Slovenian: Bolnik mora kapsule pogoltniti cele skupaj s tekočino (najbolje z vodo).
English: Each capsule contains less than 1 mmol sodium (23 mg).
Slovenian: Ena kapsula vsebuje manj kot 1 mmol natrija (23 mg).
English: Dose reduction may be necessary in patients with severe liver impairment (see section 4.2).
Slovenian: Pri bolnikih s hudo okvaro jeter utegne biti potrebno zmanjšanje odmerka (glejte poglavje 4.2).
English: Advagraf capsules contain lactose.
Slovenian: Zdravilo Advagraf kapsule vsebuje laktozo.
English: What you need to know before you take Advagraf Do not take Advagraf
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Advagraf
English: However, Advagraf is taken once daily, whereas Prograf is taken twice daily.
Slovenian: Vendar se zdravilo Advagraf jemlje enkrat na dan, zdravilo Prograf pa dvakrat na dan.
English: A strong correlation exists between AUC and whole blood trough levels at steady-state for Advagraf.
Slovenian: Obstaja močna korelacija med AUC in najnižjo koncentracijo v polni krvi v stanju dinamičnega ravnovesja za zdravilo Advagraf.
English: This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially ‘sodiumfree'.
Slovenian: Zdravilo Advagraf vsebuje manj kot 1 mmol (23 mg) natrija na kapsulo, kar v bistvu pomeni »brez natrija«.
English: Embryofoetal toxicity was observed in rats and rabbits and was limited to doses that caused significant toxicity in maternal animals.
Slovenian: Embriofetalne toksične učinke so opazili pri podganah in kuncih; omejeni so bili na odmerke, ki so povzročili izrazite toksične učinke pri samicah-materah.
English: Advagraf is routinely administered in conjunction with other immunosuppressive agents in the initial post-operative period.
Slovenian: Zdravilo Advagraf se v začetnem pooperacijskem obdobju uporablja rutinsko skupaj z drugimi imunosupresivi.
English: Advagraf dosing should primarily be based on clinical assessments of rejection and tolerability in each patient individually aided by blood level monitoring (see below under “Therapeutic drug monitoring”).
Slovenian: Odmerjanje zdravila Advagraf mora temeljiti predvsem na klinični oceni zavrnitve in prenašanja pri vsakem bolniku posebej s pomočjo spremljanja koncentracije v krvi (glejte spodaj “Spremljanje koncentracije zdravila”).
English: Absorption is variable and the mean oral bioavailability of tacrolimus (investigated with the Prograf formulation) is in the range of 20% - 25% (individual range in adult patients 6% - 43%).
Slovenian: Povprečna biološka uporabnost peroralno uporabljenega takrolimusa (raziskave so bile izvedene s farmacevtsko obliko zdravila Prograf) je od 20 do 25 % (individualni razpon pri odraslih bolnikih 6 % do 43 %).
English: Therefore, you may be more prone to infections while you are taking Advagraf.
Slovenian: Tako ste lahko med jemanjem zdravila Advagraf bolj nagnjeni k okužbam.
English: How to take Advagraf
Slovenian: Kako jemati zdravilo Advagraf
English: What Advagraf looks like and contents of the pack
Slovenian: Izgled zdravila Advagraf in vsebina pakiranja
English: The treatment difference (AdvagrafPrograf) was 3.8% (95% confidence interval [-2.1%, 9.6%]).
Slovenian: Razlika med zdravljenjem (Advagraf : Prograf) je bila 3,8 % (95 % interval zaupanja [2,1 %, 9,6 %]).
English: In stable patients converted from Prograf capsules (twice daily) to Advagraf (once daily) on a 1:1 (mg:mg) total daily dose basis, the systemic exposure to tacrolimus (AUC0-24) for Advagraf was approximately 10% lower than that for Prograf.
Slovenian: Pri stabilnih bolnikih, pri katerih je bilo zdravilo Prograf (kapsule; dvakrat na dan) zamenjano z zdravilom Advagraf (enkrat na dan) na osnovi skupnega dnevnega odmerka v razmerju 1 : 1 (mg : mg), je bila sistemska izpostavljenost takrolimusu (AUC0-24) pri zdravljenju z zdravilom Advagraf približno za 10 % nižja kot pri zdravljenju z zdravilom Prograf.
English: Tell your doctor if any of the following apply to you: - if you are taking any medicines mentioned below under ‘Other medicines and Advagraf'.
Slovenian: Povejte zdravniku, če za vas velja sledeče: - jemljete katerokoli zdravilo, ki je omenjeno v nadaljevanju v poglavju »Druga zdravila in zdravilo Advagraf«, - imate ali ste imeli težave z jetri,
English: Advagraf is taken orally once daily in the morning.
Slovenian: Zdravilo Advagraf jemljite peroralno enkrat na dan, in sicer zjutraj.
English: Monitoring of ciclosporin blood levels should be continued following conversion as the clearance of ciclosporin might be affected.
Slovenian: Koncentracijo ciklosporina v krvi je treba spremljati tudi po prehodu, ker se očistek ciklosporina lahko spremeni.
English: Following the initiation of your treatment with Advagraf, frequent blood tests will be taken by your doctor to define the correct dose.
Slovenian: Po uvedbi zdravljenja z zdravilom Advagraf bo zdravnik pogosto opravljal krvne preiskave in tako določil ustrezen odmerek.
English: Therefore, you should not breast-feed whilst using Advagraf.
Slovenian: Zato med jemanjem zdravila Advagraf ne smete dojiti.
English: Take the capsules immediately following removal from the blister.
Slovenian: Kapsule morate zaužiti takoj, ko jih vzamete iz pretisnega omota.
English: Clinical efficacy and safety of Prograf capsules bid in primary organ transplantation In prospective studies oral Prograf was investigated as primary immunosuppressant in approximately 175 patients following lung, 475 patients following pancreas and 630 patients following intestinal transplantation.
Slovenian: V prospektivnih študijah so zdravilo Prograf v peroralni obliki raziskovali kot primarni imunosupresiv pri približno 175 bolnikih po presaditvi pljuč, 475 bolnikih po presaditvi pankreasa in 630 bolnikih po presaditvi črevesa.
English: The printing ink used to mark Advagraf capsules contains soya lecithin.
Slovenian: Tiskarsko črnilo, ki se uporablja za označevanje kapsul Advagraf, vsebuje sojin lecitin.
English: Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
Slovenian: Zdravljenje zavrnitve alogenskega presadka, odporne na zdravljenje z drugimi imunosupresivi pri odraslih bolnikih.
English: A multicentre study using oral Prograf included 205 patients undergoing simultaneous pancreas-kidney transplantation who were randomised to tacrolimus (n = 103) or to ciclosporin (n = 102).
Slovenian: Multicentrična študija uporabe peroralne oblike zdravila Prograf je zajela 205 bolnikov, pri katerih je bila hkrati narejena presaditev pankreasa in ledvice; bolnike so randomizirali na takrolimus (n = 103) ali na ciklosporin (n = 102).
English: Cases of pure red cell aplasia (a very severe reduction in red blood cell counts), agranulocytosis (a severely lowered number of white blood cells), haemolytic anaemia (decreased number of red blood cells due to abnormal breakdown) and febrile neutropenia (a decrease in the type of white blood cells which fight infection, accompanied by fever) have been reported.
Slovenian: Poročali so o primerih čiste aplazije rdečih krvnih celic (hudo zmanjšanje števila rdečih krvnih celic), agranulocitozi (hudo zmanjšanje števila belih krvnih celic), hemolitični anemiji (zmanjšano število rdečih krvnih celic zaradi nenormalnega razpada) in febrilni nevtropeniji (zmanjšano število tistih belih krvnih celic, ki se bojujejo proti okužbi, ki ga spremlja povišana telesna temperatura).
English: It is possible in some cases to withdraw concomitant immunosuppressive therapy, leading to Advagraf monotherapy.
Slovenian: Včasih je mogoče sočasno imunosupresivno terapijo opustiti, kar pomeni prehod na monoterapijo z zdravilom Advagraf.
English: The incidence of efficacy failure at 12 months (defined as death, graft loss, biopsy-confirmed acute rejection, or lost to follow-up) was 14.0% in the Advagraf group (N=214), 15.1% in the Prograf group (N=212) and 17.0% in the ciclosporin group (N=212).
Slovenian: V skupini, ki je prejemala zdravilo Advagraf (n = 214), je bila izguba učinkovitosti po 12 mesecih (definirana kot smrt, odmrtje presadka, z biopsijo potrjena akutna zavrnitev ali izguba podatkov o spremljanju bolnika) 14,0 %, v skupini, ki je prejemala zdravilo Prograf (n = 212), 15,1 %, v skupini, ki je prejemala ciklosporin (n = 212), pa 17,0 %.
English: For prophylaxis of transplant rejection in adult heart allograft recipients clinical data are not yet available for Advagraf.
Slovenian: Za preprečevanje zavrnitve presadka pri odraslih po alogenski presaditvi srca klinični podatki za zdravilo Advagraf še niso na voljo.
English: The interim analysis of a recent multicentre study using oral Prograf discussed 110 patients who underwent 1:1 randomisation to either tacrolimus or ciclosporin.
Slovenian: Vmesna analiza novejše multicentrične študije obravnava uporabo peroralne oblike zdravila Prograf pri 110 bolnikih, ki so bili v razmerju 1 : 1 randomizirani na takrolimus ali ciklosporin.
English: This can lead to graft rejection or increased incidence of adverse reactions, including under- or overimmunosuppression, due to clinically relevant differences in systemic exposure to tacrolimus.
Slovenian: Takšna zamenjava lahko povzroči zavrnitev presadka ali vodi do povečanega tveganja za neželene učinke, vključno s premajhno ali preveliko imunosupresijo, zaradi klinično pomembnih razlik v sistemski izpostavljenosti takrolimusu.
English: : +372 6 056 014 Fax: +372 6 056 011
Slovenian: Biocodex OÜ Tel.: +372 6 056 014 Fax: +372 6 056 011
English: Frequent trough level monitoring in the initial two weeks post transplantation is recommended, followed by periodic monitoring during maintenance therapy.
Slovenian: V prvih dveh tednih po presaditvi priporočamo pogosto nadziranje najnižjih koncentracij, nato pa periodično med vzdrževalnim zdravljenjem.
English: Other factors observed to increase the risk of these clinical conditions included preexisting heart disease, corticosteroid usage, hypertension, renal or hepatic dysfunction, infections, fluid overload, and oedema.
Slovenian: Drugi dejavniki, za katere je ugotovljeno, da povečujejo tveganje za te klinične motnje, so obstoječa bolezen srca, jemanje kortikosteroidov, hipertenzija, moteno delovanje ledvic ali jeter, okužbe, preobremenitev s tekočino in edemi.
English: A combination of immunosuppressives such as antilymphocytic antibodies (e.g. basiliximab, daclizumab) given concomitantly increases the risk of EBVassociated lymphoproliferative disorders.
Slovenian: Pri kombiniranem zdravljenju z imunosupresivi, npr. sočasna uporaba antilimfocitnih protiteles (npr. baziliksimab, daclizumab), se tveganje za pojav z EBV povezanih limfoproliferativnih bolezni poveča.
English: Treatment of allograft rejection after kidney or liver transplantation For conversion from other immunosuppressants to once daily Advagraf, treatment should begin with the initial oral dose recommended in kidney and liver transplantation respectively for prophylaxis of transplant rejection.
Slovenian: Zdravljenje zavrnitve alogenskega presadka po presaditvi ledvic ali jeter Pri prehodu z zdravljenja z drugimi imunosupresivi na zdravljenje z zdravilom Advagraf enkrat na dan je treba zdravljenje uvesti v začetnem peroralnem odmerku, ki je priporočen za preprečevanje zavrnitve presadka po presaditvi ledvic oziroma jeter.
English: Post-transplant changes in the condition of the patient may alter the pharmacokinetics of tacrolimus and may necessitate further dose adjustments.
Slovenian: Potransplantacijske spremembe bolnikovega stanja lahko spremenijo farmakokinetiko takrolimusa in potrebne utegnejo biti dodatne prilagoditve odmerka.
English: Following conversion, tacrolimus trough levels should be monitored and if necessary dose adjustments made to maintain similar systemic exposure.
Slovenian: Po zamenjavi je treba nadzirati najnižje vrednosti takrolimusa in za ohranitev podobne sistemske izpostavljenosti po potrebi prilagoditi odmerek.
English: In patients who are hypersensitive to peanut or soya, the risk and severity of hypersensitivity should be weighed against the benefit of using Advagraf.
Slovenian: Pri bolnikih s preobčutljivostjo za arašide ali sojo je treba tehtati med pričakovano koristjo uporabe zdravila Advagraf ter tveganjem in resnostjo preobčutljivosti.
English: CYP3A4 inducers potentially leading to decreased tacrolimus blood levels Clinically the following substances have been shown to decrease tacrolimus blood levels: Strong interactions have been observed with rifampicin, phenytoin, St. John's Wort (Hypericum perforatum) which may require increased tacrolimus doses in almost all patients.
Slovenian: Induktorji CYP3A4, ki lahko vodijo do znižanih vrednosti takrolimusa v krvi Klinično je ugotovljeno, da koncentracijo takrolimusa v krvi znižujejo naslednje snovi: Močne interakcije so opazili z rifampicinom, fenitoinom in šentjanževko (Hypericum perforatum), zato je treba v takšnem primeru odmerek takrolimusa skoraj pri vseh bolnikih povečati.
English: Patients treated with immunosuppressants, including Advagraf are at increased risk for infections including opportunistic infections (bacterial, fungal, viral and protozoal) such as BK virus associated nephropathy and JC virus associated progressive multifocal leukoencephalopathy (PML).
Slovenian: Pri bolnikih, ki se zdravijo z zdravili za zaviranje imunske odzivnosti, vključno z zdravilom Advagraf, obstaja večje tveganje za pojav okužb, vključno z oportunističnimi okužbami (bakterijskimi, glivičnimi, virusnimi in protozojskimi), kot sta z virusom BK povezana nefropatija in z virusom JC povezana progresivna multifokalna levkoencefalopatija (PML).
English: Astellas Pharma Puh/Tel: + 358 9 85606000
Slovenian: Suomi/Finland Astellas Pharma Puh/Tel: + 358 9 85606000
English: Treatment of allograft rejection after heart transplantation In adult patients converted to Advagraf, an initial oral dose of 0.15 mg/kg/day should be administered once daily in the morning.
Slovenian: Zdravljenje zavrnitve alogenskega presadka po presaditvi srca Pri odraslih bolnikih je pri prehodu na zdravljenje z zdravilom Advagraf treba uvesti začetni peroralni odmerek 0,15 mg/kg/dan, ki se daje enkrat na dan, in sicer zjutraj.
English: The efficacy and safety of Advagraf and Prograf, both in combination with corticosteroids, was compared in 471 de novo liver transplant recipients.
Slovenian: Učinkovitost in varnost uporabe zdravil Advagraf in Prograf, obe zdravili v kombinaciji s kortikosteroidi, so primerjali pri 471 bolnikih z na novo presajenimi jetri.
English: The relationship between tacrolimus trough levels (C24) and systemic exposure (AUC0-24) for Advagraf is similar to that of Prograf.
Slovenian: Razmerje med najnižjimi koncentracijami takrolimusa (C24) in sistemsko izpostavljenostjo (AUC0-24) je pri zdravilu Advagraf podobno kot pri zdravilu Prograf.
English: venoocclusive liver disease, hepatitic artery thrombosis very rare:
Slovenian: venookluzivna bolezen jeter, tromboza jetrne arterije zelo redki:
English: Astellas Pharma Kft. Tel.: +36 1 577 8200
Slovenian: Magyarország Astellas Pharma Kft. Tel.: + 36 1 577 8200
English: Blood trough levels of tacrolimus should also be closely monitored following conversion from Prograf to Advagraf, dose adjustments, changes in the immunosuppressive regimen, or co-administration of substances which may alter tacrolimus whole blood concentrations (see section 4.5).
Slovenian: Najnižje koncentracije takrolimusa v krvi je treba skrbno nadzirati tudi po zamenjavi zdravila Prograf z zdravilom Advagraf, prilagoditvah odmerka, spremembah imunosupresivnega režima ali ob sočasni uporabi učinkovin, ki lahko spremenijo koncentracije takrolimusa v polni krvi (glejte poglavje 4.5).
English: The treatment difference was -3.0% (Advagrafciclosporin) (95.2% confidence interval [-9.9%, 4.0%]) for Advagraf vs. ciclosporin and -1.9% (Prografciclosporin) (95.2% confidence interval [-8.9%, 5.2%]) for Prograf vs. ciclosporin.
Slovenian: Razlika med zdravljenjem z zdravilom Advagraf in zdravljenjem s ciklosporinom (Advagraf : ciklosporin) je bila -3,0 % (95,2 % interval zaupanja [-9,9 %, 4,0 %]), razlika med zdravljenjem z zdravilom Prograf in zdravljenjem s ciklosporinom (Prograf : ciklosporin) pa -1,9 % (95,2 % interval zaupanja [-8,9 %, 5,2 %]).
English: Treatment of allograft rejection after transplantation of other allografts Although there is no clinical experience with Advagraf in lung-, pancreas- or intestine-transplanted patients, Prograf has been used in lung-transplanted patients at an initial oral dose of 0.10 - 0.15 mg/kg/day, in pancreas-transplanted patients at an initial oral dose of 0.2 mg/kg/day and in intestinal transplantation at an initial oral dose of 0.3 mg/kg/day.
Slovenian: Pri bolnikih s presajenimi pljuči, trebušno slinavko ali črevesom sicer ni kliničnih izkušenj z uporabo zdravila Advagraf, vendar pa so pri bolnikih po presaditvi pljuč uporabljali zdravilo Prograf v začetnem peroralnem odmerku od 0,10 do 0,15 mg/kg/dan, po presaditvi trebušne slinavke v začetnem peroralnem odmerku 0,2 mg/kg/dan in po presaditvi črevesa v začetnem peroralnem odmerku 0,3 mg/kg/dan.
English: Other interactions leading to clinically detrimental effects Concurrent use of tacrolimus with medicinal products known to have nephrotoxic or neurotoxic effects may increase these effects (e.g., aminoglycosides, gyrase inhibitors, vancomycin, cotrimoxazole, NSAIDs, ganciclovir or aciclovir).
Slovenian: Druge interakcije, ki povzročijo klinično škodljive učinke Te učinke lahko poveča sočasna uporaba takrolimusa in zdravil z nefrotoksičnimi ali nevrotoksičnimi učinki (kot so aminoglikozidi, zaviralci giraze, vankomicin, kotrimoksazol, nesteroidna protivnetna zdravila, ganciklovir ali aciklovir).
English: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Slovenian: Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte PrilogoI : Povzetek glavnih značilnosti zdravila, poglavje 4.2).